©The Author(s) 2026.
World J Hepatol. Feb 27, 2026; 18(2): 115763
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.115763
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.115763
Figure 3 Qushi Huoxue ointment ameliorates liver injury and inflammatory response in metabolic associated steatotic liver disease mice.
A: Serum levels of aspartate aminotransferase, alanine aminotransferase, tumor necrosis factor-α, and interleukin-β; B: Schematic diagram illustrating the relationship between hepatic lipid accumulation and liver injury. Data are presented as means ± SD; aP < 0.05, cP < 0.001. MASLD: Metabolic associated steatotic liver disease; QSHXO: Qushi Huoxue ointment; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; TNF-α: Tumor necrosis factor-α; IL-β: Interleukin-β; TC: Total cholesterol; TG: Triglyceride.
- Citation: Liu YY, Qin H, Wu HX, Wang RT, Yang QY, Jiang F, Liu XD, Wu DK, Tang YM. Qushi Huoxue ointment ameliorates metabolic associated steatotic liver disease through autophagy activation and ferroptosis inhibition. World J Hepatol 2026; 18(2): 115763
- URL: https://www.wjgnet.com/1948-5182/full/v18/i2/115763.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i2.115763